Parthenon LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.68M Sell
59,803
-1,600
-3% -$129K 0.49% 43
2026
Q1
$5.32M Sell
61,403
-235
-0.4% -$22.5K 0.61% 39
2025
Q4
$5.92M Sell
61,638
-10,331
-14% -$1M 0.64% 39
2025
Q3
$6.85M Sell
71,969
-15,268
-18% -$1.4M 0.76% 34
2025
Q2
$7.6M Sell
87,237
-2,701
-3% -$229K 0.87% 31
2025
Q1
$8.08M Sell
89,938
-248
-0.3% -$22.2K 0.99% 29
2024
Q4
$7.2M Sell
90,186
-875
-1% -$75.7K 0.87% 31
2024
Q3
$8.2M Sell
91,061
-1,045
-1% -$87.9K 0.98% 30
2024
Q2
$7.25M Sell
92,106
-1,142
-1% -$93.6K 0.92% 31
2024
Q1
$8.13M Buy
93,248
+375
+0.4% +$32K 1.03% 31
2023
Q4
$7.65M Sell
92,873
-2,650
-3% -$202K 1.06% 29
2023
Q3
$7.49M Sell
95,523
-110
-0.1% -$9.21K 1.12% 28
2023
Q2
$8.43M Buy
95,633
+100
+0.1% +$8.61K 1.22% 27
2023
Q1
$7.7M Buy
95,533
+1,765
+2% +$144K 1.18% 27
2022
Q4
$7.29M Sell
93,768
-514
-0.5% -$41.7K 1.2% 29
2022
Q3
$7.61M Sell
94,282
-361
-0.4% -$32.4K 1.37% 25
2022
Q2
$8.49M Buy
94,643
+2,205
+2% +$223K 1.44% 23
2022
Q1
$10.3M Buy
92,438
+2,660
+3% +$281K 1.49% 24
2021
Q4
$9.29M Sell
89,778
-919
-1% -$106K 1.3% 27
2021
Q3
$11.4M Buy
90,697
+185
+0.2% +$23.9K 1.71% 20
2021
Q2
$11.2M Buy
90,512
+190
+0.2% +$23.9K 1.68% 22
2021
Q1
$10.7M Sell
90,322
-57
-0.1% -$6.68K 1.72% 23
2020
Q4
$10.6M Buy
90,379
+1,983
+2% +$218K 1.83% 20
2020
Q3
$9.19M Sell
88,396
-2,018
-2% -$203K 1.78% 19
2020
Q2
$8.29M Buy
90,414
+1,240
+1% +$119K 1.72% 20
2020
Q1
$8.04M Buy
89,174
+1,105
+1% +$118K 1.91% 18
2019
Q4
$9.99M Buy
88,069
+97
+0.1% +$10.6K 1.99% 16
2019
Q3
$9.56M Sell
87,972
-873
-1% -$91.1K 2.04% 15
2019
Q2
$8.65M Buy
88,845
+5,754
+7% +$525K 1.86% 19
2019
Q1
$7.57M Sell
83,091
-2,399
-3% -$215K 1.69% 21
2018
Q4
$7.78M Buy
85,490
+10
+0% +$934 1.91% 17
2018
Q3
$8.41M Sell
85,480
-3,888
-4% -$359K 1.85% 18
2018
Q2
$7.65M Buy
89,368
+1,236
+1% +$103K 1.76% 19
2018
Q1
$7.07M Sell
88,132
-371
-0.4% -$30.6K 1.67% 19
2017
Q4
$7.15M Buy
88,503
+3,805
+4% +$305K 1.61% 20
2017
Q3
$6.59M Buy
84,698
+2,255
+3% +$187K 1.55% 21
2017
Q2
$7.32M Buy
82,443
+1,265
+2% +$107K 1.74% 17
2017
Q1
$6.54M Buy
81,178
+150
+0.2% +$11.7K 1.55% 21
2016
Q4
$5.77M Sell
81,028
-3,345
-4% -$263K 1.42% 22
2016
Q3
$7.29M Sell
84,373
-2,370
-3% -$207K 1.81% 16
2016
Q2
$7.53M Sell
86,743
-337
-0.4% -$27.3K 1.89% 16
2016
Q1
$6.53M Sell
87,080
-7,115
-8% -$536K 1.68% 18
2015
Q4
$7.25M Sell
94,195
-3,639
-4% -$274K 1.89% 14
2015
Q3
$6.55M Buy
97,834
+155
+0.2% +$11.4K 1.83% 16
2015
Q2
$7.24M Buy
97,679
+1,438
+1% +$110K 1.91% 15
2015
Q1
$7.51M Buy
96,241
+5,571
+6% +$422K 1.99% 16
2014
Q4
$6.55M Sell
90,670
-6,385
-7% -$444K 1.81% 16
2014
Q3
$6.01M Buy
97,055
+675
+0.7% +$42.9K 1.74% 17
2014
Q2
$6.14M Hold
96,380
1.82% 18
2014
Q1
$5.93M Sell
96,380
-925
-1% -$53.9K 1.78% 19
2013
Q4
$5.58M Sell
97,305
-1,250
-1% -$70.9K 1.7% 18
2013
Q3
$5.25M Sell
98,555
-250
-0.3% -$13.5K 1.74% 17
2013
Q2
$5.08M Buy
+98,805
New +$4.88M 1.71% 20

Other funds holding MDT

Parthenon LLC's MDT Position: Q2 2026 in Review

Parthenon LLC reduced its Medtronic (MDT) stake by 2.6% in Q2 2026, selling an estimated $129K and leaving 59,803 shares worth $4.68M. The position accounts for 0.49% of the portfolio, ranked #43.

Parthenon LLC first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.4M in Q3 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Parthenon LLC held 59,803 shares of Medtronic worth $4.68M as of Q2 2026.
  • Parthenon LLC sold 1,600 Medtronic shares in Q2 2026, an estimated $129K.
  • Medtronic made up 0.49% of Parthenon LLC's portfolio in Q2 2026, its #43 holding.
  • Parthenon LLC first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Parthenon LLC's Medtronic position peaked at $11.4M in Q3 2021.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Parthenon LLC's 13F filing for Q2 2026, filed 23 Jul 2026.